Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Amortization - Intangibles (2016 - 2025)

Historic Amortization - Intangibles for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Q3 2025 value amounting to $1.0 million.

  • Cumberland Pharmaceuticals' Amortization - Intangibles fell 637.05% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 4275.83%. This contributed to the annual value of $4.7 million for FY2024, which is 4139.88% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Amortization - Intangibles is $1.0 million, which was down 637.05% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Amortization - Intangibles registered a high of $4.5 million during Q4 2023, and its lowest value of $458222.0 during Q4 2022.
  • In the last 5 years, Cumberland Pharmaceuticals' Amortization - Intangibles had a median value of $1.2 million in 2023 and averaged $1.3 million.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Amortization - Intangibles skyrocketed by 89060.17% in 2023, and later crashed by 6784.77% in 2024.
  • Over the past 5 years, Cumberland Pharmaceuticals' Amortization - Intangibles (Quarter) stood at $1.0 million in 2021, then tumbled by 54.95% to $458222.0 in 2022, then surged by 890.6% to $4.5 million in 2023, then crashed by 67.85% to $1.5 million in 2024, then crashed by 30.82% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $1.0 million for Q2 2025, and $1.0 million during Q1 2025.